Propafenone and Nirmatrelvir/Ritonavir Interaction

Drug interaction information between Propafenone and Nirmatrelvir/Ritonavir.

Propafenone and Nirmatrelvir/Ritonavir have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Propafenone and Nirmatrelvir/Ritonavir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Propafenone

Class IC Antiarrhythmic

Drug B

Nirmatrelvir/Ritonavir

Antiviral (Protease Inhibitor Combination)

How They Interact

Taking these together causes propafenone to stay in your body longer and reach higher levels than intended. This can lead to serious and potentially fatal heart rhythm disturbances.

FDA Label Information

Antiarrhythmics amiodarone, dronedarone, flecainide, propafenone, quinidine ↑ antiarrhythmic Co-administration contraindicated due to potential for cardiac arrhythmias [see Contraindications (4) ] .

Frequently Asked Questions

What SPL severity band is on file for Propafenone + Nirmatrelvir/Ritonavir?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Nirmatrelvir/Ritonavir has 86 labeled pairs on file vs Propafenone's 26. In the major band specifically: Propafenone has 1; Nirmatrelvir/Ritonavir has 23 (also Simvastatin, Lovastatin, Sildenafil, Carbamazepine).

What mechanism field is on file for Propafenone and Nirmatrelvir/Ritonavir?

Taking these together causes propafenone to stay in your body longer and reach higher levels than intended. This can lead to serious and potentially fatal heart rhythm disturbances.

Nirmatrelvir/Ritonavir carries more major-labeled pairs than Propafenone

SPL source-record counts only. This page's band is major · classes on file: Propafenone (Class IC Antiarrhythmic); Nirmatrelvir/Ritonavir (Antiviral (Protease Inhibitor Combination)).

Nirmatrelvir/Ritonavir has 23 major-labeled pairs vs Propafenone's 1.

Propafenone

1 major · 3 moderate · 22 minor · 26 total

Propafenone has no other major-band peer in this dataset besides Nirmatrelvir/Ritonavir.

Nirmatrelvir/Ritonavir

23 major · 30 moderate · 33 minor · 86 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.